CareDx (CDNA) Tops Q4 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
CareDx (CNDA) PT, Estimates Cut at Piper Jaffray Post Q4
March 18, 2015 8:51 AM EDTPiper Jaffray analyst William R. Quirk lowered estimates and his price target on CareDx, Inc (NASDAQ: CDNA) to $8.00 (from $13.00) following Q4 results but maintained an Overweight rating.
Quirk commented, "CareDx reported 4Q14 revenue growth of 35.8% to $8.0M, above our ($6.7M) and consensus ($6.9M) expectations, although a... More



